Yong Liao Selected Research

Inflammation (Inflammations)

11/2023	Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway.
1/2018	Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
3/2016	Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Liao Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 10/2003
8	Infections 01/2021 - 05/2010
8	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2004
7	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
5	Carcinogenesis 07/2020 - 11/2013
4	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2019
3	Wounds and Injuries (Trauma) 05/2024 - 05/2010
3	Inflammation (Inflammations) 11/2023 - 03/2016
3	Liver Failure 01/2023 - 01/2022
3	Insulin Resistance 01/2018 - 01/2016
2	Portal Hypertension 01/2023 - 01/2022
2	Poisoning 11/2022 - 01/2021
2	Fibrosis (Cirrhosis) 09/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 08/2021 - 01/2018
2	Pathologic Processes 01/2019 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2017 - 12/2007
2	Fungemia 12/2015 - 08/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2015 - 04/2014
2	Invasive Fungal Infections 07/2012 - 01/2012
2	Hypoxia (Hypoxemia) 10/2010 - 09/2010
1	Starvation 12/2023
1	Nephrolithiasis 11/2023
1	Hepatic Encephalopathy 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 12/2022
1	Bites and Stings (Sting) 09/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 09/2022
1	Epilepsy (Aura) 07/2022
1	End Stage Liver Disease 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 08/2021
1	Vomiting 08/2021
1	Weight Gain 08/2021
1	Diarrhea 08/2021
1	Nausea 08/2021
1	Adenocarcinoma 01/2021
1	Allergic Rhinitis 01/2021
1	Residual Neoplasm 09/2020
1	Diabetes Mellitus 01/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2022 - 10/2003
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2004
3	Phosphotransferases (Kinase)IBA 09/2022 - 09/2004
3	Messenger RNA (mRNA)IBA 09/2022 - 01/2019
3	Insulin (Novolin)FDA Link 08/2021 - 01/2017
3	Long Noncoding RNAIBA 01/2021 - 07/2017
2	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2023
2	UbiquitinIBA 12/2023 - 06/2019
2	CytokinesIBA 11/2023 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2009
2	TriazolesIBA 01/2021 - 12/2015
2	Estrogens (Estrogen)FDA Link 07/2020 - 11/2013
2	Factor V (Coagulation Factor V)IBA 07/2018 - 01/2015
2	CaspasesIBA 01/2017 - 01/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2008 - 09/2004
2	Therapeutic UsesIBA 12/2007 - 09/2004
1	Small Cytoplasmic RNAIBA 05/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	InflammasomesIBA 11/2023
1	polydatinIBA 11/2023
1	AmmoniaIBA 01/2023
1	CreatinineIBA 01/2023
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023
1	LigandsIBA 01/2023
1	Competitive Endogenous RNAIBA 12/2022
1	Methylene Chloride (Dichloromethane)IBA 11/2022
1	Collagen Type IV (Type IV Collagen)IBA 09/2022
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 09/2022
1	InterferonsIBA 09/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2022
1	PerforinIBA 09/2022
1	shenkangIBA 09/2022
1	Toll-Like Receptor 4IBA 07/2022
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 07/2022
1	lenvatinibIBA 01/2022
1	BilirubinIBA 01/2022
1	AlbuminsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 08/2021
1	Insulin Glargine (Lantus)FDA Link 08/2021
1	Exenatide (Byetta)FDA Link 08/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Sulfates (Sulfates, Inorganic)IBA 01/2021
1	SulfurIBA 01/2021
1	yu ping feng sanIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	ProteomeIBA 01/2021
1	isothiocyanic acidIBA 07/2020
1	sulforaphaneIBA 07/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2020

Therapy/Procedure

6	Therapeutics 01/2019 - 09/2004
4	Drug Therapy (Chemotherapy) 06/2019 - 09/2004
3	Hepatectomy 01/2023 - 01/2022
2	Catheters 01/2016 - 05/2015
1	Transjugular Intrahepatic Portasystemic Shunt 01/2023
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023
1	Intraperitoneal Injections 07/2022
1	Glycemic Control 08/2021
1	Precision Medicine 01/2021
1	Chemoradiotherapy 09/2020
1	Aftercare (After-Treatment) 09/2020